Javascript must be enabled to continue!
Ovarian Cancer Immunity
View through CrossRef
Epithelial ovarian cancer (EOC) is a significant cause of cancer-related mortality in women, and there has been no substantial decrease in the death rates due to EOC in the past three decades. Thus, basic knowledge regarding ovarian tumor cell biology is urgently needed to allow the development of innovative treatments for EOC. Traditionally, EOC has not been considered an immunogenic tumor, but there is evidence of an immune response to EOC in patients. Clinical data demonstrate that an anti-tumor immune response and immune evasion mechanisms are correlated with a better and lower survival, respectively, providing evidence for the immunoediting hypothesis in EOC. This chapter focuses on the immune response and immune suppression in EOC.
Oxford University Press
Title: Ovarian Cancer Immunity
Description:
Epithelial ovarian cancer (EOC) is a significant cause of cancer-related mortality in women, and there has been no substantial decrease in the death rates due to EOC in the past three decades.
Thus, basic knowledge regarding ovarian tumor cell biology is urgently needed to allow the development of innovative treatments for EOC.
Traditionally, EOC has not been considered an immunogenic tumor, but there is evidence of an immune response to EOC in patients.
Clinical data demonstrate that an anti-tumor immune response and immune evasion mechanisms are correlated with a better and lower survival, respectively, providing evidence for the immunoediting hypothesis in EOC.
This chapter focuses on the immune response and immune suppression in EOC.
Related Results
Ovarian Cancer Immunotherapy
Ovarian Cancer Immunotherapy
Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as sta...
Prevention of cancer
Prevention of cancer
In the UK, the four commonest cancers—lung cancer, breast cancer, colon cancer, and prostate cancer—result in around 62 000 deaths every year. Although deaths from cancer have fall...
Ovarian Stimulation
Ovarian Stimulation
Ovarian stimulation is the starting point of reproductive medicine but the procedure can result in adverse reactions particularly the dangerous ovarian hyperstimulation syndrome. F...
Clinical approach to suspected cancer
Clinical approach to suspected cancer
Lung cancer 4Breast cancer 5Urological cancer 6Nervous system tumours 7Upper gastrointestinal cancer 8Lower gastrointestinal cancer 9Gynaecological cancer 10Haematological cancer 1...
PD-1/PDL-1 Inhibitors as Immunotherapy for Ovarian Cancer
PD-1/PDL-1 Inhibitors as Immunotherapy for Ovarian Cancer
Programmed death 1 (PD-1), a member of the B7-CD28 immunoglobulin superfamily, and its ligands PD-L1/PD-L2 inhibit T-cell activation. They also play a key role in the tumor microen...
Accomplishments in Cancer Epidemiology
Accomplishments in Cancer Epidemiology
In his chapter “Accomplishments in Cancer Epidemiology,” Dr. MacMahon summarizes the history of the discipline, particularly the epidemiologic evidence on cigarette smoking, ionizi...
Principles of oncogenesis
Principles of oncogenesis
It is obvious that the process of developing cancer—oncogenesis—is a multistep process. We know that smoking, obesity, and a family history are strong independent predictors of dev...
Screening for cancer
Screening for cancer
The aim in cancer screening is not just to prevent the incidence of disease or diagnose it in an early stage but, most importantly, to reduce mortality. Designing screening program...

